Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Nevro News

    11,60 € -2,52% -0,30 €
    08:05:49 Uhr Frankfurt aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A12EPL
    ISIN: US64157F1030
    US-Symbol: NVRO
    Typ: Aktie

    Nevro News

    17.04.24 - PR Newswire
    Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
    Nevro to Report First-​Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024 PR Newswire
    28.02.24 - PR Newswire
    Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
    Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw PR Newswire
    21.02.24 - PR Newswire
    Nevro Enters Into Cooperation Agreement With Engaged Capital
    Nevro Enters Into Cooperation Agreement With Engaged Capital PR Newswire
    21.02.24 - PR Newswire
    Nevro Reports Fourth-Quarter and Full-Year 2023 Financial Results
    Nevro Reports Fourth-​Quarter and Full-Year 2023 Financial Results PR Newswire
    01.02.24 - PR Newswire
    Nevro Announces Consensus Statement Supporting High-Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy
    Nevro Announces Consensus Statement Supporting High-​Frequency (10 kHz) Spinal Cord Stimulation Therapy for Refractory Painful Diabetic Neuropathy PR Newswire
    29.01.24 - PR Newswire
    Nevro to Report Fourth-Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024
    Nevro to Report Fourth-​Quarter and Full-Year 2023 Financial Results and Host Conference Call on February 21, 2024 PR Newswire
    18.01.24 - PR Newswire
    Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy
    Nevro Announces Positive Coverage Update from Carelon Healthcare for the Treatment of Painful Diabetic Neuropathy PR Newswire
    17.01.24 - PR Newswire
    Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting
    Nevro to Highlight 25 Scientific Abstracts at 2024 North American Neuromodulation Society (NANS) Annual Meeting PR Newswire
    09.01.24 - PR Newswire
    Nevro Announces Preliminary Fourth-Quarter and Full-Year 2023 Revenue Results
    Nevro Announces Preliminary Fourth-​Quarter and Full-Year 2023 Revenue Results PR Newswire
    04.01.24 - PR Newswire
    Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference
    Nevro to Present at 42nd Annual J.P. Morgan Healthcare Conference PR Newswire
    30.11.23 - PR Newswire
    Nevro Announces Acquisition of Vyrsa™ Technologies
    Nevro Announces Acquisition of Vyrsa™ Technologies PR Newswire
    20.11.23 - PR Newswire
    Nevro Delivers Long-Term Relief with High-Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-Surgical Refractory Back Pain
    Nevro Delivers Long-Term Relief with High-​Frequency Spinal Cord Stimulation: 24-Month Data Demonstrates Profound Improvements for Non-​Surgical Refractory Back Pain PR ...
    01.11.23 - PR Newswire
    Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance
    Nevro Reports Third Quarter 2023 Financial Results, Provides Fourth Quarter Guidance and Updates Full-Year 2023 Guidance PR Newswire
    04.10.23 - PR Newswire
    Nevro to Report Third Quarter 2023 Financial Results
    Nevro to Report Third Quarter 2023 Financial Results PR Newswire
    18.09.23 - PR Newswire
    New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy
    New Data Demonstrate the Health Economic Benefits of Nevro's High-​Frequency Spinal Cord Stimulation Therapy PR Newswire
    23.08.23 - PR Newswire
    Nevro Announces Participation in Upcoming Investor Conferences
    Nevro Announces Participation in Upcoming Investor Conferences PR Newswire
    16.08.23 - PR Newswire
    New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy
    New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy PR Newswire
    10.08.23 - PR Newswire
    Nevro announces launch of HFX Connect™ in Europe and CE marking of expanded labelling for the HFX™ SCS system.
    Nevro announces launch of HFX Connect™ in Europe and CE marking of expanded labelling for the HFX™ SCS system. PR Newswire
    01.08.23 - PR Newswire
    Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance
    Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance PR Newswire
    13.07.23 - PR Newswire
    Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference
    Nevro Announces Presentations at American Society of Pain & Neuroscience Fifth Annual Conference PR Newswire

    Newssuche

    Videos

    09:30 Uhr +23,58%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »